Keywords: Targeted Genetics, Genzyme, Amsterdam Molecular Therapeutics, Glybera, Asset sales, Milestones

Targeted Genetics gets $7 million milestone under deal with Genzyme, and another from AMT

Article | 11 February 2010

Targeted Genetics says that it has completed the technology transfer portion of the September 2009 asset sale transaction executed with fellow ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Genzyme

Go to company listing